Regentis Biomaterials (RGNT) Payables (2024 - 2025)

Regentis Biomaterials' (RGNT) quarterly Payables came in at $2.6 million in Q4 2025, up 53.05% year-on-year from $1.7 million in Q4 2024, and up 53.05% on a QoQ basis from $1.7 million in Q4 2024.

Regentis Biomaterials (RGNT) Payables (2024 - 2025) Analysis & Trends

Regentis Biomaterials (RGNT) has 2 years of Payables data on file, last reported at $2.6 million in Q4 2025.

  • On a quarterly basis, Payables rose 53.05% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $2.6 million, a 53.05% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 53.05% from the prior year.
  • Payables for Q4 2025 stood at $2.6 million, up from $1.7 million in the prior quarter.
  • Over the last five years, Payables for RGNT reached as high as $2.6 million in Q4 2025 and fell as low as $1.7 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 919.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 277.20 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 5.93 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 932.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 533.23 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 252.70 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 233.30 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 699.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 123.72 Mn
10 Regentis Biomaterials 1.10 Mn -6.28 Mn - 2.61 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.61 Mn
Dec 31, 2024 1.70 Mn